Unsere Publikationen

Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol

Link
https://doi.org/10.2196/resprot.4473
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Vormfelde SV, Ortler S, Ziemssen T.
Verlag
JMIR Res Prot 2016;5(1).
Zum Eintrag

Real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients

Link
https://doi.org/10.1007/s00415-016-8058-7
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Calabrese P, Penner IK, Apfel R.
Verlag
J Neurol 2016;263(4):784-791.
Zum Eintrag

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

Link
https://doi.org/10.1212/nxi.0000000000000228
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Thomas K, Eisele J, Rodriguez-Leal FA, Hainke U, Ziemssen T.
Verlag
Neurol Neuroimmunol Neuroinflamm 2016;3(3).
Zum Eintrag

Laquinimod in the treatment of relapsing remitting multiple sclerosis

Link
https://doi.org/10.1080/17425255.2016.1179279
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Hainke U, Thomas K, Ziemssen T.
Verlag
Expert Opin Drug Metab Toxicol 2016;12(6):701-709.
Zum Eintrag

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies

Link
https://doi.org/10.1186/s12974-016-0635-2
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Sehr T, Proschmann U, Thomas K, Marggraf M, Straube E, Reichmann H, Chan A, Ziemssen T.
Verlag
J Neuroinflammation. 2016 Jun 27;13(1):164.
Zum Eintrag

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

Link
https://doi.org/10.1186/s12883-016-0625-0
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, Mäurer M, Haas J, Stangel M, Meergans M, Harlin O, Hartung HP.
Verlag
BMC Neurol. 2016 Jul 12;16:98.
Zum Eintrag

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)

Link
https://doi.org/10.1186/s12883-016-0629-9
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Engelmann U, Jahn S, Leptich A, Kern R, Hassoun L, Thomas K.
Verlag
BMC Neurol. 2016 Jul 19;16:109.
Zum Eintrag

Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod

Link
https://doi.org/10.1186/s12883-016-0648-6
Tags
Multiple SkleroseMS Behandlung
Jahr
2016
Autoren
Ziemssen T, Kern R, Cornelissen C.
Verlag
BMC Neurol 2016;16(1).
Zum Eintrag
11 12 13 14 15

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-